Stroke trials in Ghana

2 trials · From ClinicalTrials.gov, checked 10 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment II Study (SMAART II)

  Where

  Kumasi

  Age

  18 years to 100 years

  People

  1,000 worldwide

  Run by

  Northern California Institute of Research and Education

  See details and how to joinNCT05963568
• Phase 3Not yet taking people in Ghana
  CiLostAzol for pReventIon of Recurrent sTroke in Africa

  Where

  Kumasi

  Age

  30 years and over

  People

  1,100

  Run by

  Northern California Institute of Research and Education

  See details and how to joinNCT06919835